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jected to secondary screening using samples available from the Suita Study (n=3,228) and Nomura Study (n=2,895). We confirmed that AC and BNP are affected by a functional polymorphism in ALDH2 and polymorphisms in the 3' region of NPPB, respectively.
Methods

Study Subjects
Suita Study Subjects (n=936, age range: 42-73 years, Table S1 ) who were not receiving medication for hypertension were selected from the Suita Study as the initial screening sample. The design of the Suita Study has been described previously. [13] [14] [15] In brief, the sample consisted of 14,200 men and women (30-79 years of age at enrollment, stratified by gender and 10-year age groups (10 groups with 1,420 participants in each group) who had been randomly selected from the municipal population registry. They were all invited by letter to attend regular follow-up examinations (every 2 years). Samples for genetic analysis were available for 3,228 participants (Table S1) . BP was measured after 10 min of rest in the sitting position. SBP and DBP values were the means of 2 physician-obtained measurements. Physicians collected detailed personal medical information directly from the participants. The diagnosis of hypertension was based on BP measurement (SBP ≥140 mmHg or DBP ≥90 mmHg) or the current use of antihypertensive medications. Only those who gave written informed consent were included in the study.
Concentrations of PRA (n=2,328), PAC (n=2,382) and BNP (n=1,984) were measured in consecutive participants who were recruited during a defined period. PRA, PAC and BNP values were all log-transformed for statistical analyses. Residuals of SBP, DBP and PP were calculated by adjusting for age and BMI. Residuals of PR, BMI and WHR were calculated by adjusting for age and sex. Residuals of PRA, PAC and BNP were calculated by adjusting for sex and age. Residuals of PAC were also calculated by adjusting for PRA, sex and age (PAC corrected by PRA). Residuals of SM (number of cigarettes smoked per day) were calculated by adjusting for sex and age. Residuals of AC (grams of ethanol consumed per day) were calculated by adjusting for sex, height and age. The study protocol was approved by the Institutional Ethics Committee and the Committee on Genetic Analysis and Gene Therapy of the National Cerebral and Cardiovascular Center.
Nomura Study Study participants were selected from the residents of a community of 11,000 inhabitants in the Ehime Prefecture, a largely rural area located in western Japan. 16 Subjects were recruited during a community-based annual medical check-up in 2002 for self-employed people and included farmers, foresters, employees of small companies and the elderly without fixed employment. Baseline clinical characteristics (n=2,895, Table S2 ) were obtained from personal health records evaluated during the medical check-up. The values of SBP and DBP were measured after at least 5 min of rest. Hypertension status was defined as SBP ≥140 mmHg, DBP ≥90 mmHg or treatment with antihypertensive medication. Other characteristics, including smoking status and details of AC, medication, and history of cardiovascular disease, were investigated during individual interviews using a structured questionnaire. All study procedures were approved by the Ethics Committee of Ehime University Graduate School of Medicine, and written informed consent was obtained from all participants. 
Genotyping Assays
Genome-wide scans were performed for 936 Japanese participants using the Illumina Sentrix Human Hap550 BeadChip (538,732 SNP, Illumina Inc, San Diego, CA, USA), as previously reported. 17 Genotyping was performed by Illumina Inc. SNP with a call rate of less than 95% and/or with a minor allele frequency of less than 0.1 were excluded from the study, which left 368,274 autosomal SNP for analysis. Deviation from Hardy -Weinberg Equilibrium and the degree of linkage disequilibrium (LD) were analyzed using HaploView 4.0 (http://www.broad.mit.edu/mpg/haploview/). The topranked SNP were selected and genotyped in the available Suita samples (n=3,228) and then in the Nomura samples (n=2,895) for the validation of associations. Genotyping was performed by using TaqMan allelic discrimination assays (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's instructions.
Statistical Analysis
Data are expressed as the mean ± standard deviation. Continuous variables were tested for the normality of distribution, and those with skewed distributions were log-transformed. Residuals of various phenotypes, defined as the observed values minus the predicted values on the basis of confounding factors, were used for a genotype -phenotype association analysis by a one-way analysis of variance. The level of genome-wide significance, expressed as a -log10P value, was adjusted for multiple testing by use of the Bonferroni correction and was set at a -log10P value of >7.03. The odds ratio (OR) and 95% confidence interval (CI) were estimated by logistic regression analysis with adjustment for confounding factors. Statistical analysis was performed using the JMP statistical package 7.0 (SAS Institute, Cary, NC, USA). 
Results
SBP, DBP, PP and PR
None of the SNP except for rs1652080 (-log10P =7.87) exceeded the genome-wide significance level for SBP. Of the top 15 SNP in SBP, 11 SNP (4.69< -log10P <7.87) listed in Table 1 were subjected to a validation study using the available samples from the Suita Study (total Suita samples). Four SNP (rs7224748, rs7225525, rs743093, rs9389418) were excluded due to tight LD with one of these 11 SNP. The initial associations became less significant in these 11 SNP. Due to the high prevalence of antihypertensive therapy (23.5% among women and 29.0% among men: Table S1 ), analyses were also carried out using the BP trait as a dichotomous variable (hypertensive vs non-hypertensive) ( Table 1,  see Table S3 for more details). We think the latter analysis is more reliable for identification of SNP influencing BP levels in populations with high prevalence of antihypertensive medications.
The top 5 SNP in DBP (4.92<-log10P<5.63, 3 SNP were included in the top 15 in SBP) were further genotyped for validation. Again, the initial associations became less significant in these 5 SNP ( Table 1, see Table S3 for more details).
Other Phenotypes
None of the SNP exceeded the genome-wide significance level for BMI, WHR, PRA, PAC or PAC corrected by PRA. Two SNP (rs6676300 and rs198388) exceeded the genomewide significance level for BNP; -log10P values for rs6676300 and rs198388 were 8.89 and 7.97, respectively. These associations were validated in subsequent association analyses using the total Suita samples ( Table S4 ). An increase in the sample size strengthened the associations for rs6676300 Due to the overlap between the top-ranked SNP for SBP and DBP, 13 SNP in total were selected for validation in the Suita Study. *P values were obtained from association analyses with the residuals of SBP or DBP values among subjects who were not receiving antihypertensive medication; † P values were derived from association analyses using a dichotomous trait (hypertensive vs non-hypertensive) while adjusting for age and BMI; SNP shown in bold were further investigated in the Nomura Study (see Table 2 for more details). SNP, single nucleotide polymorphisms; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index. HIURA Y et al. *P values were derived from the association analyses using a dichotomous trait (hypertensive vs non-hypertensive) with adjustment for age and BMI, † rs1460138 was added after additional genotyping of 5 SNP around rs7692053. OR, odds ratio; CI, confidence interval. Other abbreviations see in Table 1 . GWAS of Hypertension in a Japanese Population and rs198388; -log10P, 13.24 for rs6676300 and 12.71 for rs198388. The minor alleles of rs6676300 and rs198388 were associated with higher levels of BNP. Two SNP (rs2789567 and rs11717167) exceeded the genome-wide significance level for a SM. However, the initial association was not reproduced in the subsequent validation study (data not shown).
As clearly shown in the Manhattan plot for AC (Figure 1) , 20 SNP on Ch12 exceeded the genome-wide significance level, with -log10P values ranging from 7.23 to 18.16. As our research group has previously reported using the Suita Study, 18 rs671 located in the ALDH2 gene at Ch12q24.2 was identified as a casual polymorphism. This Glu487Lys missense mutation confers a low Km for ALDH2 enzymatic activity. Although rs671 is the major determinant of AC, especially among Japanese men, rs671 was not covered on the Illumina chip used in the present study. We used rs671 for the rest of our analyses. The influence of this polymorphism on drinking behavior was reconfirmed in the Nomura Study (Table S5) . Sex-specific analyses revealed that the association was stronger in men than in women in both of the studies. Among the top-ranked SNP for AC, 2 SNP were not located on chromosome 12; rs4859731 on chromosome 4 (-log10P, 8.88) and rs482079 on chromosome 6 (-log10P, 7.19). The initial associations observed for these 2 SNP were not reproduced in the subsequent validation study (data not shown).
Further Analyses of rs6676300 and rs671
As summarized in Table S4 , we genotyped several SNP around rs6676300 using the total Suita samples. The SNP rs632793 was found to be the most significant SNP for BNP, with a -log10P value of 14.67. Age, BMI, PP, hematocrit, PRA and rs632793 influenced plasma BNP levels (P<0.0001, respectively). Several polymorphisms in this region have been reported to be associated not only with plasma BNP and atrial natriuretic peptide levels but also with BP levels. 19 However, the rs632793 polymorphism was not associated with the prevalence of hypertension (Figure 2 ) or BP levels (Table S3) in the Suita Study. The sample size of the Suita Study might have been too small to detect the influence of the rs632793 polymorphism on BP. Thus, the influence of this polymorphism on BP was also assessed in the Nomura Study to increase the statistical power. However, no significant influence of this polymorphism on BP was observed even after the 2 study populations were combined (Figure 2 and Table S3 ). Excessive alcohol intake conferred by the ALDH2 genotype has been reported to be associated with hypertension in Figure 2 . NPPB rs632793 genotypes and hypertension. Major homozygotes (AA) were compared to those with at least 1 minor allele (AG+GG) by multiple logistic regression analyses. Odds ratios and 95% confidence intervals are shown. Age, body mass index, and study population (Nomura or Suita) were included as confounding factors. No significant effect of this polymorphism on hypertension as a categorical variable (hypertensive vs non-hypertensive) was observed even when the 2 study populations were combined. 
men. 18,20
This was confirmed among men in the Nomura Study (Figure 3) . When participants with the Glu/Glu genotype were compared to those with at least 1 low-risk allele (Lys), the OR for the prevalence of hypertension was 1.64 (95%CI, 1.39-1.95; -log10P =8.03; Figure 3 ) in men. The inclusion of AC in the multiple logistic regression analysis attenuated the significance of the ALDH2 genotype (-log10P = 4.36).
Further Analyses of Top-Ranked SNP in SBP and DBP As described above, the initial associations of the top 13 SNP in SBP and DBP became less significant with an increase in the sample size. However, there were nominally significant associations between 8 SNP and BP traits in the total Suita samples, when residuals of SBP (P<0.01) and a dichotomous trait (hypertensive vs non-hypertensive) (P<0.05) were both taken into account. Therefore, we assessed these 8 SNP in the Nomura Study ( Table 2 and Table S3 ). The associations with hypertension as a categorical variable (hypertensive vs non-hypertensive) became more significant with an increase in the sample size in the 5 SNP (rs1652080, rs3778297, rs6013382, rs7692053 and rs7747460). Although they were weakened by an increase in the sample size, nominal P-values for the other 2 SNP (rs1075609 and rs9973037) were still below 0.05. However, the reproducibility of the associations with BP values was not high (Table S3) . Only 2 SNP (rs1652080 and rs6013382) gave associations of P<0.05 with BP levels in the Nomura Study. The SNPs rs3765258, rs3778297 and rs7747460 were all located on chromosome 6q23 and there was tight LD among them. Additional typing of 5 SNP around rs7692053 indicated that hypertension as a dichotomous trait (hypertensive vs non-hypertensive) was most strongly associated with rs1460138 (OR =1.374, P= 0.0001, Table 2 ).
Identification of associations with various intermediate phenotypes might be useful for elucidating the pathophysiological significance of SNP. Significant associations with renin profiles were observed for 4 SNP (rs10757609, rs3778297, rs6013382 and rs7747460, see Table S6 ). The SNP rs1460138 (in LD with rs7692053) significantly influenced the relationship between ethanol consumption and BP levels ( Figure S1 ).
Discussion
Although the genetic architecture of many common diseases has been determined by GWAS, there has been limited success with GWAS for hypertension. Recently, 2 large GWAS of BP levels have been reported. The first included 34,433 participants of European ancestry for genome-wide screening and 71,225 participants from European-based populations and 12,889 non-Europeans for validation. 4 The other study included 29,136 particpants for genome-wide association analysis and 34,433 participants for replication. 3 Despite the large sample sizes used in these studies, only 2 chromosomal regions have been consistently reported to affect SBP (CYP17A1 and SH2B3). Top-ranked SNP that affected SBP, DBP and/or hypertension status in 1 study were not reproduced in the other study. 3,4,9-11 While this might indicate that the contribution of a common polymorphism in a single gene is too small to be detected (lack of sample power), it could also be due to heterogeneity of the etiology of hypertension or the importance of rare functional mutations.
The present study was the first GWAS of hypertensionrelated phenotypes conducted in a Japanese population. Only one SNP (rs1652080) exceeded the genome-wide significance level for SBP. Moreover, the initially observed associations were not strengthened in the subsequent validation studies. These observations suggest that the sample power of the present GWAS might have been too low to identify SNP that influence SBP or DBP, and that there are no master genes that profoundly affect SBP or DBP in Japanese. This situation appears to be true for PP, PR, BMI, WHR, PRA, PAC, and PAC corrected by PRA and SM.
In contrast, the SNP that affect AC and BNP exceeded the genome-wide significance level, and subsequent validation studies confirmed that these associations were valid.
The SNP rs671, a missense mutation in ALDH2, has been repeatedly reported to influence AC in Japanese, particularly among men. 18, 20 The present GWAS indicated that no other master genes influenced AC in this population. The Suita and Nomura Studies have confirmed that this functional polymorphism is associated with the prevalence of hypertension in men through its effect on alcohol intake. Although the inclusion of AC in the model for the multiple logistic regression analysis attenuated the significance of the ALDH2 genotypes, it could still be considered that ALDH2 genotypes might influence BP, independent of AC. We speculate that the underreporting of AC, which often occurs among heavy drinkers, might have exaggerated the influence of the ALDH2 genotype on BP.
The SNP at the NPPA-NPPB locus have been reported to influence plasma BNP levels and BP. 19 The present study confirmed that plasma BNP levels were profoundly influenced by rs632793 in a Japanese population. However, no significant influence of the rs632793 polymorphism on BP was observed in our 2 study populations. A previous study reported that the SNP rs5068 and rs198358 affected SBP by only 0.9-1.5 mmHg. 19 The SNP rs5068 has been reported not to exist in Asians. The SNP rs198358 was in tight LD with rs6676300. No significant influence of rs6676300 on BP was observed in the Suita Study. It is likely that a much larger study population will be necessary to confirm the possible influence of rs632793 or other SNP at the NPPA-NPPB locus on BP in Japanese. It can also be speculated that a prolonged elevation of plasma BNP levels might reduce sensitivity to BNP and this polymorphism might not influence BP levels.
Validation studies of top-ranked SNP with regard to their influence on SBP and DBP showed that none of the SNP achieved genome-wide significance levels. However, 8 SNP or 6 chromosomal regions (including rs1460138 added after additional typing around rs7692053) exhibited nominal P-values for hypertension (as a categorical variable) below 0.05 after we combined the 2 study populations ( Table 1) . Notably, the associations became stronger when we combined the 2 study populations for 5 of the 8 SNP (or 3 out of the 6 chromosomal regions).
Identification of associations not only with BP but also with various intermediate phenotypes can be very important for determining how such genetic susceptibility contributes to hypertension and what strategies might be useful in terms of treatment and/or prevention. In this sense, the associations of the 4 SNP (rs10757609, rs3778297, rs6013382 and rs7747460, Table S6 ) with renin profiles are interesting. They might contribute to salt sensitivity in Japanese. Likewise, the significant influence of rs1460138 on the relationship between ethanol consumption and BP levels was intriguing ( Figure S1) . Participants with the CC + AC genotype of rs1460138 should be advised not to drink too much. The SNP identified in the present study are excellent candidates for hypertension-susceptible genes in a Japanese population GWAS of Hypertension in a Japanese Population and merit further investigation using much larger study populations.
GWAS is regarded as a useful method to identify genes or genetic loci involved in pathogenic pathways without a priori biological knowledge. Concerning the genetic determinants of inter-individual differences in drug responses, pharmacogenetic studies have been rigorously performed. 21, 22 This pharmacogenetic approach might be further expanded with the discovery of new genes or genetic variants through GWAS.
The present study was the first GWAS of hypertensionrelated phenotypes in a Japanese population. Even though our genome-wide screen was conducted in a medium-sized population, SNP that influence AC and BNP were confirmed in the present study. It appears that there is no master gene in Japanese that profoundly affects SBP, DBP, PP, PR, BMI, WHR, PRA, PAC, or PAC corrected by PRA or SM. However, several candidate SNP relevant to hypertension in Japanese were identified.
Study Limitations
To identify polymorphisms with minor to moderate influence, screening for genome-wide association analyses should be performed with a much larger sample size and subsequent validation studies should be done in more than tens of thousands of participants. However, because the influence of a genetic susceptibility will be modulated by interaction with various environmental factors, thorough and accurate information on individual clinical, behavioral, and habitual characteristics will be necessary. These antithetical difficulties might be resolved by the establishment of an international consortium on various phenotypes. Table S1 . Clinical Characteristics of the Study Populations: the Suita Study Table S2 . Clinical Characteristics of the Study Population: the Nomura Study  Table S3 . Validation of the Top-Ranked SNP for SBP and DBP and Candidate SNP Relevant to Hypertension  Table S4 . Validation of BNP-Associated SNP, rs6676300 and rs198388, and Their Nearby SNP Table S5 . The Effect of rs671 Genotypes on Alcohol Consumption Table S6 . Renin-Aldosterone Profile and Candidate SNP Relevant to Hypertension Figure S1 . Multiple logistic regression analyses indicated that hypertension status (hypertensive vs non-hypertensive) was associated with age (P<0.0001), BMI (P<0.0001), study population (Nomura or Suita Study) (P<0.0001), ethanol consumption (P<0.0001), rs1460138 (AA vs AC + CC, P=0.0007), and the interaction between ethanol and rs1460138 (P=0.0019). Data S1. The top 1,000 SNP for SBP, DBP, PP, PR, BMI, WHR, PRA, PAC, PAC adjusted for PRA, BNP, SM and AC are listed in a supplementary file.
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